CardioKinetix Secures $4,000,000 Series E Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce0df807-2608-4bcb-940a-4781179275bb&Preview=1 -
Date
2/28/2013 -
Company Name
CardioKinetix -
Mailing Address
925 Hamilton Avenue Menlo Park, CA 94025 -
Company Description
CardioKinetix, Inc. is developing new technology for treating Congestive Heart Failure (CHF). This is a catheter-based intervention implanted into the heart. CHF results from damage to the heart from several causes, which affects nearly five million people in the U.S. -
Website
http://www.cardiokinetix.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,000,000 -
Transaction Round
Series E -
Proceeds Purposes
Specific proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Panorama Capital
